Holman Division of Endocrinology, Diabetes & Metabolism Publications
Research conducted by NYU Langone’s Holman Division of Endocrinology, Diabetes, and Metabolism appears in leading academic and medical publications.
Defining prediabetes remission as a distinct prevention endpoint
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:100-102
Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial
Lancet. Diabetes & endocrinology. 2026 Feb ; 14:123-136
Young Adult Diabetes Technology Use in Pediatric as Compared to Adult Practices
Endocrine practice. 2026 Jan ; 32:11-15
Superiority of 1 h plasma glucose vs fasting plasma glucose, 2 h plasma glucose and HbA1c for the diagnosis of type 2 diabetes
Diabetologia. 2025 Dec 12;
Medical Therapies of Cushing's Disease-Part 1
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:609-626
Adipose microsomal triglyceride transfer protein deficiency protects against hepatic steatosis by upregulating PPARα activity
JJHEP reports : innovation in hepatology. 2025 Dec ; 7:101549
Extracellular Vesicles From Chylomicron-Treated Endothelial Cells Drive Macrophage Inflammation
Arteriosclerosis, thrombosis, & vascular biology. 2025 Dec ; 45:2179-2195
Medical Therapies of Cushing's Disease-Part 2
Endocrinology & metabolism clinics of North America. 2025 Dec ; 54:627-635